Diskussion zur BICO Group Aktie WKN: A2PX00 ISIN: SE0013647385 Forum: Aktien User: Hedgehog3

Danke ebenfalls

Danke fürs teilen.

Statement from BICO regarding counterclaims in patent lawsuit by Organovo against group company CELLINK Due to recently filed counterclaims in patent lawsuit by Organovo, Inc., (“Organovo”) to the Federal Court in Delaware, BICO Group AB (“BICO”) releases the following statement to explain the background and context. BICO, CELLINK and all our group companies respect valid intellectual property and believe that Organovo’s patent claims at issue are invalid, not infringed, or both. We look forward to coming to a favourable resolution and will provide updates as they become available. The products concerned are expected to account for approximately 1-2 percent of the Group's estimated revenues in 2022 and therefore this is non-material for the Group. BICO remains steadfastly committed to evolving the future of health. As the world’s leading bio convergence company, we look forward to continuing to set the trends in the bio convergence space and collaborating with our industry peers to work toward solving the major health challenges we face as a society. Background CELLINK filed a complaint for a declaratory judgment in June 2021 to the U.S. District Court in Delaware about non-infringement of certain of Organovo’s patents in order to strengthen our market position and freedom to operate. In July, 2021, Organovo, filed a patent infringement action against CELLINK in the U.S. District Court in the Western District of Texas, asserting that a single CELLINK product family infringes four U.S. patents. Organovo’s Texas Court Action was later, in December 2021, transferred to the Delaware Court and both cases will from now on be tried by the Delaware court. The so-called counterclaims filed by Organovo in January 2022 refers to the transferred claims from the Texas Court. We strongly oppose the counter claim, and our standpoint is clear: Organovo’s patent claims at issue are invalid, not infringed, or both. kam gerade rein

https://news.cision.com/bico-group/r/statement-from-bico-regarding-counterclaims-in-patent-lawsuit-by-organovo-against-group-company-cell,c3484476

https://simplywall.st/stocks/se/pharmaceuticals-biotech/sto-bico/bico-group-shares/news/co-founder-erik-gatenholm-just-bought-a-handful-of-shares-in

dito

wir sind gerade auf dem Kursniveau vom 29.09.20 angekommen... schon was her

Habe doch gar nicht gesagt, dass die böse sind. Sie setzen auf rot und wir auf weiß. Da ist keiner von beiden irgendwie ein böser Bube. Nur haben HF oft tiefere Einblicke in das Unternehmen als wir Kleinstaktionäre.

Ja wahrscheinlich wissen die HF mehr als der Gründer, der für 2 Millionen € nachgekauft hat...

Hf?

Oh ja die bösen HF.

Da kann man mir sagen was man will, die HF wissen etwas, wovon wir noch keine Ahnung haben!

An der Hauptbörse Schweden sind wir bei -1% heute. Hochgekauft wurde gestern im Ausland nach Börsenschluss in Schweden.

Nach den -10% vllt doch nochmal nachlegen…schon verlockend 😅

Naja… sagen wir es so…. Die chance lebt dann zumindest noch. Einverstanden?